• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

面部基底细胞癌肿瘤学安全切缘的缩小会导致更高的复发率吗?

Does reduction of the oncologic safety margin for facial basal cell carcinoma result in higher recurrence rates?

作者信息

Kim Eon Su, Yang Chae Eun, Chung Yoon Kyu

机构信息

Department of Plastic and Reconstructive Surgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.

出版信息

Arch Craniofac Surg. 2021 Jun;22(3):135-140. doi: 10.7181/acfs.2021.00206. Epub 2021 Jun 25.

DOI:10.7181/acfs.2021.00206
PMID:34225404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8257443/
Abstract

BACKGROUND

Wide surgical excision is the gold standard for basal cell carcinoma (BCC) treatment. Typically, resection requires a safety margin ≥ 4 mm. We aimed to confirm BCC excisions' cancer recurrence rate and safety on the facial region with new safety margins.

METHODS

We included patients with primary BCC on the facial region who underwent wide excision with 2- or 3-mm safety margins at our institution between January 2010 and December 2018. Medical records were reviewed to confirm the epidemiology and surgical information. Recurrence was confirmed by physical examination through regular 6-month follow-up.

RESULTS

We included 184 out of 233 patients in this study after applying the exclusion criteria. The mean age and follow-up period were 71.2± 10.2 years and 29.3± 13.5 months, respectively. The predominantly affected area was the nose (95 cases); a V-Y advancement flap was the most commonly used surgical method. There were two cases of recurrence in the 2 mm margin group and one recurrence in the group resected with 3 mm margins.

CONCLUSION

In this large cohort study, we found 2-3 mm excision margins can yield enough safety in facial BCCs. The recurrence rates were found to be comparable with those reported after wider margins.

摘要

背景

广泛手术切除是基底细胞癌(BCC)治疗的金标准。通常,切除需要≥4mm的安全切缘。我们旨在确定采用新的安全切缘对面部区域进行BCC切除后的癌症复发率及安全性。

方法

我们纳入了2010年1月至2018年12月期间在我院接受2mm或3mm安全切缘广泛切除的面部原发性BCC患者。查阅病历以确认流行病学及手术信息。通过定期6个月随访的体格检查确认复发情况。

结果

应用排除标准后,本研究纳入了233例患者中的184例。平均年龄和随访时间分别为71.2±10.2岁和29.3±13.5个月。主要受累部位为鼻子(95例);V-Y推进皮瓣是最常用的手术方法。2mm切缘组有2例复发,3mm切缘切除组有1例复发。

结论

在这项大型队列研究中,我们发现2 - 3mm的切除切缘对面部BCC可产生足够的安全性。发现复发率与更宽切缘切除后报道的复发率相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4939/8257443/9dc8c8a3f141/acfs-2021-00206f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4939/8257443/bd35d183c3eb/acfs-2021-00206f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4939/8257443/9dc8c8a3f141/acfs-2021-00206f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4939/8257443/bd35d183c3eb/acfs-2021-00206f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4939/8257443/9dc8c8a3f141/acfs-2021-00206f2.jpg

相似文献

1
Does reduction of the oncologic safety margin for facial basal cell carcinoma result in higher recurrence rates?面部基底细胞癌肿瘤学安全切缘的缩小会导致更高的复发率吗?
Arch Craniofac Surg. 2021 Jun;22(3):135-140. doi: 10.7181/acfs.2021.00206. Epub 2021 Jun 25.
2
Is a 3 mm Surgical Margin Safe for Basal Cell Carcinoma in the Head and Neck that is Less than 2 cm, Considering Different Risk Factors?考虑不同风险因素时,3毫米的手术切缘对于头颈部小于2厘米的基底细胞癌是否安全?
Arch Plast Surg. 2024 Aug 6;51(5):487-494. doi: 10.1055/a-2338-9192. eCollection 2024 Sep.
3
A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.一项对694例基底细胞癌切除术的回顾性研究,旨在量化与组织学类型和手术切缘相关的深部切缘记录及切缘情况。
J Plast Reconstr Aesthet Surg. 2019 Nov;72(11):1805-1812. doi: 10.1016/j.bjps.2019.06.002. Epub 2019 Jun 27.
4
Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.界限清楚的原发性面部基底细胞癌窄切缘切除的疗效
J Am Acad Dermatol. 2005 Sep;53(3):464-8. doi: 10.1016/j.jaad.2005.03.038.
5
Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision.基底细胞癌的外科治疗:关于影响初次切除不完全风险因素的病例系列研究
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2518-2525. doi: 10.1111/jdv.16327. Epub 2020 Apr 13.
6
Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.全标本术中冰冻切片分析。1082例基底细胞癌的经验。
Eur J Surg Oncol. 2018 Jan;44(1):157-162. doi: 10.1016/j.ejso.2017.11.004. Epub 2017 Nov 23.
7
Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.手术切除后面部基底细胞癌复发的危险因素:一项随访分析。
J Plast Reconstr Aesthet Surg. 2017 Dec;70(12):1738-1745. doi: 10.1016/j.bjps.2017.04.006. Epub 2017 May 3.
8
Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.预测面部基底细胞癌复发的临床和病理参数:在一家高级护理中心的回顾性审计
Int J Dermatol. 2016 Nov;55(11):1281-1288. doi: 10.1111/ijd.13341.
9
[The clinical features and surgical treatment of facial basal cell carcinoma].[面部基底细胞癌的临床特征及外科治疗]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Feb;32(4):279-281. doi: 10.13201/j.issn.1001-1781.2018.04.008.
10
Recurrence of Basal Cell Carcinoma Treated with Surgical Excision and Histopathological Analysis with Frozen Section Technique with Complete Margin Control (CMC-FS): A 15-Year Experience of a Reference Center.采用手术切除及冰冻切片技术进行组织病理学分析并实现切缘完全控制(CMC-FS)治疗基底细胞癌的复发情况:一家参考中心的15年经验
Cancers (Basel). 2023 Jul 28;15(15):3840. doi: 10.3390/cancers15153840.

引用本文的文献

1
Minimizing Surgical Margins in Basal Cell Carcinoma: A Single Institution's Experience with Excision and Reconstruction Methods.基底细胞癌手术切缘的最小化:单机构的切除与重建方法经验
Arch Plast Surg. 2024 Dec 27;52(1):30-35. doi: 10.1055/s-0044-1788780. eCollection 2025 Jan.
2
Adequacy of surgical margins, re-excision, and evaluation of factors associated with recurrence: a retrospective study of 769 basal cell carcinomas.切缘充分性、再次切除以及与复发相关因素的评估:769 例基底细胞癌的回顾性研究。
An Bras Dermatol. 2023 Jul-Aug;98(4):449-459. doi: 10.1016/j.abd.2022.07.005. Epub 2023 Mar 16.
3
Facial basal cell carcinoma: A retrospective study of 67 cases.

本文引用的文献

1
Basal cell carcinoma misdiagnosed as trichoepithelioma.被误诊为毛发上皮瘤的基底细胞癌。
Arch Craniofac Surg. 2020 Jun;21(3):202-205. doi: 10.7181/acfs.2020.00157. Epub 2020 Jun 29.
2
A retrospective study of changes in skin cancer characteristics over 11 years.一项关于11年间皮肤癌特征变化的回顾性研究。
Arch Craniofac Surg. 2020 Apr;21(2):87-91. doi: 10.7181/acfs.2020.00024. Epub 2020 Apr 20.
3
Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer.非黑色素瘤皮肤癌的循证手术治疗建议的回顾与更新。
面部基底细胞癌:67例回顾性研究。
World J Clin Cases. 2023 Mar 6;11(7):1488-1497. doi: 10.12998/wjcc.v11.i7.1488.
4
Surgical refinement of the purse-string suture for skin and soft tissue defects of the head and neck.头部和颈部皮肤及软组织缺损荷包缝合术的手术改良
Arch Craniofac Surg. 2021 Aug;22(4):183-192. doi: 10.7181/acfs.2021.00297. Epub 2021 Aug 20.
Dermatol Clin. 2019 Oct;37(4):425-433. doi: 10.1016/j.det.2019.05.002. Epub 2019 Jul 10.
4
Current Basal and Squamous Cell Skin Cancer Management.当前基底细胞和鳞状细胞皮肤癌的管理。
Plast Reconstr Surg. 2018 Sep;142(3):373e-387e. doi: 10.1097/PRS.0000000000004696.
5
Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention.基底细胞癌:诊断、治疗和预防的当代方法。
J Am Acad Dermatol. 2019 Feb;80(2):321-339. doi: 10.1016/j.jaad.2018.02.083. Epub 2018 May 19.
6
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.基底细胞皮肤癌,1.2016 年版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2016 May;14(5):574-97. doi: 10.6004/jnccn.2016.0065.
7
Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.基底细胞癌:发病机制、流行病学、临床特征、诊断、组织病理学及治疗
Yale J Biol Med. 2015 Jun 1;88(2):167-79. eCollection 2015 Jun.
8
Study to determine whether intraoperative frozen section biopsy improves surgical treatment of non-melanoma skin cancer.研究以确定术中冰冻切片活检是否能改善非黑色素瘤皮肤癌的手术治疗。
Mol Clin Oncol. 2013 Mar;1(2):390-394. doi: 10.3892/mco.2012.51. Epub 2012 Dec 14.
9
Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations.晚期基底细胞癌:流行病学与治疗创新
Curr Dermatol Rep. 2014 Feb 9;3(1):40-45. doi: 10.1007/s13671-014-0069-y. eCollection 2014.
10
Age distribution of patients with advanced non-melanoma skin cancer in the United States.美国晚期非黑素瘤皮肤癌患者的年龄分布。
Arch Dermatol Res. 2013 Nov;305(9):845-50. doi: 10.1007/s00403-013-1357-2. Epub 2013 Apr 21.